ENTPD1 and neoplasm: We also observed that PD-1hi Prolif increased expression of both PD-1 and CD39 from pre-treatment to C2D1 (Fig. 3B), yielding a PD-1hi CD39 + phenotype associated with T cell exhaustion and tumor specificity [22, 23].